Bispecific binding agents binding to cldn18.2 and cd3
US-2026035458-A1 · Feb 5, 2026 · US
This page is not indexed by search engines while we improve data quality.
Astellas Pharma Europe Bv patents
Astellas Pharma Europe Bv holds 4 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 4 |
| Recent patents | 3 |
| First publication | May 4, 2023 |
| Latest publication | Feb 5, 2026 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Bispecific binding agents binding to cldn18.2 and cd3
US-2024018234-A1 · Jan 18, 2024 · US
Bispecific binding agents binding to CLDN18.2 and CD3
US-11739145-B2 · Aug 29, 2023 · US
Bispecific binding agents binding to cldn18.2 and cd3
US-2023137677-A1 · May 4, 2023 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Bispecific binding agents binding to cldn18.2 and cd3
US-2026035458-A1 · Feb 5, 2026 · US
Bispecific binding agents binding to cldn18.2 and cd3
US-2024018234-A1 · Jan 18, 2024 · US
Bispecific binding agents binding to CLDN18.2 and CD3
US-11739145-B2 · Aug 29, 2023 · US
Bispecific binding agents binding to cldn18.2 and cd3
US-2023137677-A1 · May 4, 2023 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 4 |
| Chemistry & Metallurgy | 4 |